Strength in Numbers
Our clients and their pharmaceutical projects benefit from Tapemark's deep resources within the industry. We commit to partnerships with potential to make a significant impact on patient health. Our ideal partner shares our commitment to breakthrough science and the vision to make a lasting contribution to people’s health.
Rutgers Center for Dermal Research. Its vision is to be the premier dermatopharmaceutics research center conducting studies on topical and transdermal compound delivery, skin biology, and skin tissue engineering. The CDR also provides quality educational opportunities for its members through workshops, seminar series, symposia, and courses.
For early-stage companies needing venture services and entrepreneurs building their dreams, RevRoad offers a unique model of accelerator, agency, and venture capital. RevRoad works with pharmaceutical client businesses at any level of growth to help scale efforts. Grow, scale, and multiply your profits all under one roof.
Biotts is a Polish biotechnical company that develops proprietary drug delivery technologies in the field of oncology, dermatology, and autoimmune diseases. Biotts proprietary technology combined with Tapemark’s world-leading expertise in transdermal patch design, development, and manufacturing combine to create MacroPerm™.
10x Technology provides Tapemark with a sustainable manufacturing process ensuring consistent and precision replication of MicroDerm™. The dual investment in transdermal pharmaceutical research and development benefits patients around the world suffering from unmet needs due to various diseases and medical ailments.